Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-0761 in CCR4-positive Peripheral T/NK-cell Lymphoma
NCT01192984Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Sep 2010
- Primary completion
- May 2012
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of mogamulizumab in peripheral T-cell lymphoma (PTCL), natural killer cell lymphoma, sponsored by Kyowa Kirin. Started Sep 2010; status: completed.
02
Drugs
mogamulizumab
03
Conditions
peripheral T-cell lymphoma (PTCL)natural killer cell lymphoma
Beyond the preview
Go deeper on NCT01192984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01192984.